Search by Drug Name or NDC

    NDC 51754-0105-08 Acetylcysteine 200 mg/mL Details

    Acetylcysteine 200 mg/mL

    Acetylcysteine is a ORAL; RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is ACETYLCYSTEINE.

    Product Information

    NDC 51754-0105
    Product ID 51754-0105_5cc9bfdb-0160-4a8c-a85f-d1fe0f95c8c3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Acetylcysteine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetylcysteine Solution
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL; RESPIRATORY (INHALATION)
    Active Ingredient Strength 200
    Active Ingredient Units mg/mL
    Substance Name ACETYLCYSTEINE
    Labeler Name Exela Pharma Sciences, LLC
    Pharmaceutical Class Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205643
    Listing Certified Through 2024-12-31

    Package

    NDC 51754-0105-08 (51754010508)

    NDC Package Code 51754-0105-8
    Billing NDC 51754010508
    Package 3 VIAL in 1 CARTON (51754-0105-8) / 30 mL in 1 VIAL
    Marketing Start Date 2023-11-13
    NDC Exclude Flag N
    Pricing Information N/A